
Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma
0:00
9:42
Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma.
Read the full article:
Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Altri episodi di "The Lancet Diabetes & Endocrinology in conversation with"



Non perdere nemmeno un episodio di “The Lancet Diabetes & Endocrinology in conversation with”. Iscriviti all'app gratuita GetPodcast.







